ArticleCancers2021

Tumor-Associated Trypsin Inhibitor (TATI) as a Biomarker of Poor Prognosis in Oropharyngeal Squamous Cell Carcinoma Irrespective of HPV Status.

Anni Sjöblom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.